PlainRecalls
FDA Drug Moderate Class II Terminated

Trimix BM3 Papaverine 60 mg/Phentolamine 4 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1310-03

Reported: November 7, 2018 Initiated: September 10, 2018 #D-0192-2019

Product Description

Trimix BM3 Papaverine 60 mg/Phentolamine 4 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1310-03

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
Pharm D Solutions, LLC
Units Affected
67 milliliters
Distribution
Nationwide
Location
Houston, TX

Frequently Asked Questions

What product was recalled?
Trimix BM3 Papaverine 60 mg/Phentolamine 4 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1310-03. Recalled by Pharm D Solutions, LLC. Units affected: 67 milliliters.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on November 7, 2018. Severity: Moderate. Recall number: D-0192-2019.